Back to Journals » OncoTargets and Therapy » Volume 9
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Next-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: a review of the evidence
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
15,624 | Dovepress* | 13,032+ | 1,803 | 14,835 | |
PubMed Central* | 2,592 | 1,101 | 3,693 | ||
Totals | 15,624 | 2,904 | 18,528 | ||
*Since 6 September 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 1 |
View citations on PubMed and Google Scholar